We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Lugol's Solution Stabilized with PVP for Gram Stain

By LabMedica International staff writers
Posted on 03 Jan 2011
Lugol's solution is an aqueous solution, which contains iodine (I2) and potassium iodide (KI) in a ratio of 1:2.

Used for Gram staining, Lugol's iodine solution is required to form the dye-iodine complex of Gram-positive bacteria. More...
It can also be used as an antiseptic and disinfectant for emergency disinfection of drinking water, and as a reagent for starch detection in routine laboratory and other medical tests.

Stock solutions of I2 - KI in water are unstable. Iodine can be lost by evaporation and that can influence the result of the staining as well as affecting the working conditions in that area. Stainless steel parts of staining instruments can also be affected by the iodine in the Lugol's solution. If the concentration of iodine in the Lugol's solution decreases, the bacterial smears may become more susceptible to decolorization.

The problem of iodine loss can be overcome by using polyvinylpyrrolidine (PVP) in the I2 - KI solution. PVP forms a complex with iodine. This complex is more stable and has a longer shelf life. Material treated with Lugol's solution stabilized with PVP will give identical results with regard to differentiation of Gram-positive and Gram-negative bacteria compared to the standard Lugol's solution.

In the standard Gram procedure, the aniline dyes in the cell tissue of microorganisms form a red dye-iodine complex when exposed to iodine. In Gram-positive microorganisms, the dye-iodine complex cannot subsequently be dissolved from the cells by decolorizing agents such as alcohol or acetone. The cells remain dark blue in color. In Gram-negative microorganisms, the dye-iodine complex is dissolved and the cell turns red as a result of counterstaining.

Both Lugol's solutions (the standard type and the stabilized type) are available for bacteriological staining from Merck KGaA (Darmstadt, Germany), or EMD Chemicals (Gibbstown, NJ, USA) in the USA. Suitable protocols are available on the internet or on demand.

Related Links:
Merck KGaA
EMD Chemicals




Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
POC Immunoassay Analyzer
Procise DX
Gold Member
Electrolyte Analyzer
CBS-4000 (CBS-400)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Study design and workflow (Parankusham H, Vanderlip C, Birkenbihl C, et al. A two-stage plasma biomarker algorithm reduces amyloid PET use and the p-Tau217 gray zone. Annals of Clinical and Translational Neurology. Published online October 19, 2026. doi:10.1002/acn3.70560)

Two-Step Blood Biomarker Algorithm Clarifies Uncertain Alzheimer’s Amyloid Status

Blood-based biomarkers offer a more accessible, less expensive way to detect Alzheimer’s-related brain changes than traditional methods such as amyloid-beta positron emission tomography (Aβ-PET).... Read more

Molecular Diagnostics

view channel
Image

GeneDx Presents Evidence for Wider Clinical Use of Genomic Sequencing at ASHG 2026

GeneDx (Gaithersburg, MD, USA) is presenting 27 scientific abstracts at the American Society of Human Genetics (ASHG) 2026 Annual Meeting, taking place October 20–24 in Montreal, Canada.... Read more

Immunology

view channel
Image Credit: iStock

Antibody Profiling Predicts Inflammatory Bowel Disease Years Before Diagnosis

Inflammatory bowel disease (IBD), which includes Crohn’s disease and ulcerative colitis, involves abnormal immune responses that cause persistent inflammation and damage in the digestive system.... Read more

Pathology

view channel
Image: HETA Quality Control identifies slide quality issues before analysis, while HETA Tumor Detect annotates tumor regions and flags slides likely to contain tumor during scanning. (Photo courtesy of Aignostics)

AI Pathology Platform Targets Workflow Delays and Molecular Test Failures

Pathology laboratories often rely on visual review of tissue slides to assess quality, identify tumors, count mitoses, and estimate tumor content. These tasks can be time-consuming and vary between readers,... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image: The acquisition of Reveal Genomics would expand Hologic’s oncology diagnostics portfolio to support treatment decisions for more women with breast cancer.

Hologic to Broaden Breast Cancer Testing Portfolio Through Reveal Genomics Acquisition

Hologic (Marlborough, MA, USA) has signed a definitive agreement to acquire Reveal Genomics (Barcelona, Spain), a precision oncology company developing genomic diagnostic tests to help personalize cancer treatment.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.